Lymph node metastases in papillary thyroid cancer detected by quantitative real-time polymerase chain reaction for thyroglobulin and cytokeratin 19

Polish Journal of Pathology

Volumn 64, Issue 2, 2013, Pages 90-95

  Kaczka, Krzysztof ^a   Fendler, Wojciech ^a   Borowiec, Maciej ^a   Młynarski, Wojciech ^a   Celnik, Agnieszka ^a   Pomorski, Lech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Histopathology; Lymph node metastases; Quantitative real time PCR for CK19 mRNA; Quantitative real time PCR for TG mRNA; Thyroid cancer

Indexed keywords

CYTOKERATIN 19; THYROGLOBULIN; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; BIOSYNTHESIS; CARCINOMA; HUMAN; LYMPH NODE METASTASIS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

AREA UNDER CURVE; CARCINOMA; HUMANS; KERATIN-19; LYMPHATIC METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880283244     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/PJP.2013.36007     Document Type: Article

References (40)

1. Gagel RF, Goepfert H, Callender DL. Changing concepts in the pathogenesis and management of thyroid carcinoma. CA Can-cer J Clin 1996; 46: 261-283.
2. Beasley NJ, Lee J, Eski S, et al. Impact of nodal metastaseson prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngolog Head Neck Surg. 2002; 128: 825-828.
3. Costa S, Giugliano G, Santoro L, et al. Role of prophylactic cen-tral neck dissection in cN0 papillary thyroid cancer. Acta Otorhi-nolaryngol Ital 2009; 29: 61-69.
4. Bhattacharyya N. A population-based analysis of survival fac-tors in differentiated and medullary thyroid cancer. Otolaryn-golog Head Neck Surg 2003; 128: 115-123.
5. Steinmüller T, Klupp J, Rayes N, et al. Prognostic factors in pa-tients with differentiated thyroid cancer. Eur J Surg 2000; 166: 29-33.
6. Ward LS, Souza SL, Assumpçao LV. The impact of nodal metas-tases on prognosis of well-differentiated thyroid cancer suggests the practice of prophylactic neck dissection. Arch Otolaryngolog Head Neck Surg 2003; 9: 495-496.
7. Cisco RM, Shen WT, Gosnell JE. Extent of surgery for papil-lary thyroid cancer: preoperative imaging and role of prophy-lactic and therapeutic neck dissection. Curr Treat Options On-col 2012; 13: 1-10.
8. Caglià P, Zappulla E, Costa S, et al. Differentiated thyroid can-cer: role of the lymph node dissection. G Chir 2010; 31: 293-295.
9. Kandil E, Friedlander P, Noureldine S, et al. Impact of exten-sive neck dissection on survival from papillary thyroid cancer. ORL J Otorhinolaryngol Relat Spec 2011; 73: 330-335.
10. Cisco RM, Shen WT, Gosnell JE. Extent of surgery for papil-lary thyroid cancer: preoperative imaging and role of prophy-lactic and therapeutic neck dissection. Curr Treat Options On-col 2012; 13: 1-10.
11. Shindo M, Stern A. Total thyroidectomy with and without se-lective central compartment dissection: a comparison of com-plication rates. Arch Otolaryngol Head Neck Surg 2010; 136: 584-587.
12. Raijmakers PG, Paul MA, Lips P. Sentinel node detection in pa-tients with thyroid cancer: a meta-analysis. World J Surg 2008; 32: 1961-1967.
13. Balasubramanian SP, Harrison BJ. Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 2011; 98: 334-344.
14. Kaczka K, Celnik A, Luks B, et al. Sentinel lymph node biop-sy techniques in thyroid pathologies - a meta-analysis. Endokrynol Pol 2012; 63: 222-231.
15. Ece H, Devrim CD, Pelin TA, et al. Clinical experience of thy-roid carcinoma: a study of 178 cases. Wspolczesna Onkol 2012; 16: 218-22.
16. Weaver DL. The prognostic importance of isolated tumor cell clusters and micrometastases in sentinel lymph nodes. Cancer Invest 2009; 27: 121-128.
17. Ge MJ, Wu QC, Wang M, et al. Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK19 reverse transcriptase polymerase chain reaction and its clinical signifi-cance. J Cancer Res Clin Oncol 2005; 131: 662-668.
18. Saintigny P, Coulon S, Kambouchner M, et al. Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagno-sis of lymph node micrometastases in non small cell lung can-cer. Int J Cancer 2005; 115: 777-782.
19. Taniyama K, Motoshita J, Sakane J, et al. Combination analy-sis of a whole lymph node by one-step nucleic acid amplifica-tion and histology for intraoperative detection of micrometas-tasis. Pathobiology 2006; 73: 183-191.
20. Chen G, McIver CM, Texler M, et al. Detection of occult metas-tasis in lymph nodes from colorectal cancer patients: a multi-ple-marker reverse transcriptase-polymerase chain reaction study. Dis Colon Rectum 2004; 47: 679-686.
21. Wascher RA, Bostick PJ, Huynh KT, et al. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes. Br J Can-cer 2001; 85: 1340-1346.
22. Merrie AE, Yun K, McCall JL. Detection of carcinoembryon-ic antigen messenger RNA in lymph nodes from patients with colorectal cancer. N Engl J Med 1998; 131: 662-668.
23. Denninghoff VC, Kahn AG, Falco J, et al. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study. Mol Diagn 2004; 8: 253-258.
24. Demeure M, Doffek K, Komorowski R, et al. Adenocancer of the pancreas-detection of occult metastases in lymph nodes by polymerase chain reaction-bassed assay. Cancer 1998; 83: 1328-1334.
25. Samancilar O, Kaya SO, Ceylan KC, et al. The effect of TTF-1 expression on ipsilateral mediastinal nodal (N2) metastases in primary adenocarcinoma of the lung. Wspolczesna Onkol 2012; 16: 516-519.
26. Kaczka K, Jakubiak-Wielganowicz M, Zawlik I, et al. Nodal status in the papillary thyroid cancer. Comparison of the results of routine histopathological examination, immmunohisto-chemistry and reverse transcription-polymerase chain reaction. Neoplasma 2008; 55: 513-518.
27. Weber T, Amann K, Weckauf H, et al. Detection of dissemi-nated medullary thyroid cancer cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction. World J Surg 2002; 26: 148-152.
28. Zhu X, Sun T, Lu H et al. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid can-cer. J Clin Pathol 2010; 63: 786-789.
29. Tong J, Wang Y, Da JP Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid pap-illary microcancer from benign lesions. Zhonghua Zhong Liu Za Zhi 2011; 33: 599-604.
30. Song Q, Wang D, Lou Y, et al. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid car-cinoma in the northeastern region of China. Diagn Pathol 2011; 6: 126.
31. Pomorski L, Kaczka K, Piaskowski S, et al. Detection of lymph node metastases of papillary thyroid cancer-comparison of the results of histopathology, immunohistochemistry and reverse tran-scription-polymerase chain reaction-a preliminary report. Lan-genbecks Arch Surg 2005; 390: 209-215.
32. Herman K, Jarzab M. Endocrine tumors. In: Recommendations for diagnosis and treatment of malignant tumors. Krzakow-ski M (ed.). Via Medica, Gdańsk 2011; 358-373.
33. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007; 13: 4807-4816.
34. Rahbari NN, Bork U, Motschall E, et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 2012; 30: 60-70.
35. Gubała E, Handiewicz-Junak D, Zeman M, et al. Thyroglob-ulin RT-PCR method for detection of lymph node metastases during the course of differentiated thyroid cancer. Wiad Lek 2001; 54: 349-356.
36. Raphael SJ, McKeown-Eyssen G, Asa SL, et al. High-molecu-lar-weight cytokeratin and cytokeratin-19 in the diagnosis of thy-roid tumors. Mod Pathol 1994; 7: 295-300.
37. Schelfhout LJ, Van Muijen GN, Fleuren GJ. Expression of ker-atin 19 distinguishes papillary thyroid cancer from follicular can-cers and follicular thyroid adenoma. Am J Clin Pathol 1989; 92: 654-658.
38. Beasley MF, McLaren KM. Cytokeratin 19 and galectin-3 im-munohistochemistry in the differential diagnosis of solitary thy-roid nodules. Histopathology 2002; 41: 236-243.
39. Baloch ZW, Abraham S, Roberts S, LiVolsi VA. Differential ex-pression of cytokeratins in follicular variant of papillary cancer: an immunohistochemical study and its diagnostic utility. Hum Pathol 1999; 30: 1166-1171.
40. Miettinen M, Kovatich AJ, Kärkkäinen P. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications. Virchows Arch 1997; 431: 407-413.